Sign Up
Stories
Adial Pharmaceuticals Raises $3.5M for Drug Development
Share
Adial Pharmaceuticals Boosts AD04 Develo...
Adial Pharmaceuticals Raises Funds for A...
ADMA Biologics CFO Transition Announceme...
ADMA Biologics CFO Transition Revealed
ADOCIA Files 2023 Registration Document
Overview
API
Adial Pharmaceuticals discloses the exercise of warrants for $3.5 million gross proceeds, aimed at funding general corporate activities and advancing clinical work on AD04 for Alcohol Use Disorder.
Ask a question
How does the reliance on warrants for funding affect Adial Pharmaceuticals' financial strategy and growth trajectory?
How might the additional funding accelerate the development of AD04 for Alcohol Use Disorder treatment?
What potential impact could AD04 have on the treatment landscape for Alcohol Use Disorder?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Mar 2024
Coverage
finan
globe